Meningococcal Vaccines
VIDEO: ‘It’s an exciting time’ for meningococcal vaccination
NEW YORK — In this video at the Infectious Diseases in Children Symposium, Catherine Mary Healy, MBBCh, describes what she called “an exciting time” for meningococcal vaccines.
ACIP votes to simplify meningococcal B vaccine recommendations
A CDC advisory committee on Thursday voted unanimously to “harmonize” serogroup B meningococcal vaccine recommendations for healthy adolescents and young adults and children who have a higher risk for infection.
FDA accepts GSK’s pentavalent meningococcal vaccine for review
The FDA will review GSK’s pentavalent meningococcal vaccine candidate for approval, the company announced Tuesday.
FDA approves Penbraya for protection against meningococcal disease in young patients
Pfizer announced that the FDA has approved Penbraya, the first and only pentavalent vaccine for coverage against the most common serogroups causing meningococcal disease in people aged 10 to 25 years, according to a company press release.
CDC investigating 'one of the worst' meningococcal outbreaks in US history
The CDC is strongly recommending men who have sex with men living in Florida get a meningococcal vaccine in response to an outbreak that has sickened 24 people and killed seven.
Meningococcal vaccination rates low among patients with complement component deficiencies
Meningococcal vaccination rates are low among eligible patients with complement component deficiencies, according to a study of U.S. data.
Pentavalent meningococcal vaccine shows promise in phase 2 trial
An investigational pentavalent vaccine for Neisseria meningitidis showed promise in a phase 2 trial conducted among toddlers in Mali, researchers reported in The New England Journal of Medicine.
How to answer patients’ questions about ‘rare, extremely serious’ meningococcus B
CDC data show that cases of meningococcal disease caused by serogroup B in the United States is at an all-time low — only 0.11 cases per 100,000 people in 2017.